Policy | February 09, 2024
Growth of Ayush sector is bound to happen: Kotecha
Ayush is expanding beyond wellness to therapeutic wellness
Ayush is expanding beyond wellness to therapeutic wellness
Glenmark Pharmaceuticals won Innovation of the Year award
The event will have a mix of policymakers, national and international leaders from the pharma industry, MSME, innovators, academic and research fraternity
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
The proposed week-long event will comprise specific themes - International engagements, market access and incubation support, funding support to startups etc. and will cover the different areas of the innovation lifecycle
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
_256_384.jpg)
The focus of this year’s challenge is to find solutions within Covid management and treatment of cardiovascular, renal, neuro, cancer and lung diseases
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
The Govt. launched the PLI scheme for bulk drugs with a financial outlay of Rs 6,940 crores across 53 APIs over 6 years.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)